Concordance Between Peri-Areolar Blue Dye and Peri-Incisional Radiotracer Injections for Sentinel Node Mapping in Patients with a History of Primary Breast Cancer Excisonal Biopsy

Abstract

Background: We evaluated the concordance between peri-areolar blue dye and peri-incisional radiotracer injections for axillary sentinel node mapping of patients with the history of previous breast lesion excisional biopsy. Methods: 80 patients with the history of previous excisional biopsy of the breast lesions were included. All patients received two injections of 99mTc-antimony sulfide colloid in both ends of incision line in an intradermal fashion. 2 mL patient blue V dye was injection to all patients in the peri-areolar area of the index quadrant after induction of anesthesia. All blue or hot nodes were harvested as sentinel lymph nodes.

Results: At least one sentinel node could be detected during surgery in 79 patients. In total 94 sentinel nodes were detected. All detected sentinel nodes were hot. In three patients sentinel nodes were detected by gamma probe but not blue dye. The tumor location in all of these patients was in the upper lateral quadrant and the incision line was extended into the axillary tail of the breast in all of them. 91 out of 94 sentinel nodes were stained blue, which amounts to 95.8% concordance between blue dye and radiotracer on a per node analysis.

Conclusions: Single peri-areolar injection in the index quadrant would suffice for sentinel node mapping of patients with history of excisional biopsy. Care should be taken in patients with large excisional biopsy in the extreme proximity to axilla.

Additional information

Notes on contributors

M. Mehrabibahar

S. Ramin, M.D., Assistant Professor Nuclear Medicine Research Center Mashhad University of Medical Sciences Imam Reza Hospital Ebn Sina Street Mashhad, Iran Tel.: [phone] Fax: [phone] E-mail: [email protected]; [email protected]

S. Azizi

S. Ramin, M.D., Assistant Professor Nuclear Medicine Research Center Mashhad University of Medical Sciences Imam Reza Hospital Ebn Sina Street Mashhad, Iran Tel.: [phone] Fax: [phone] E-mail: [email protected]; [email protected]

A. Jangjoo

S. Ramin, M.D., Assistant Professor Nuclear Medicine Research Center Mashhad University of Medical Sciences Imam Reza Hospital Ebn Sina Street Mashhad, Iran Tel.: [phone] Fax: [phone] E-mail: [email protected]; [email protected]

E. Saremi

S. Ramin, M.D., Assistant Professor Nuclear Medicine Research Center Mashhad University of Medical Sciences Imam Reza Hospital Ebn Sina Street Mashhad, Iran Tel.: [phone] Fax: [phone] E-mail: [email protected]; [email protected]

V.R. Dabbagh Kakhki

S. Ramin, M.D., Assistant Professor Nuclear Medicine Research Center Mashhad University of Medical Sciences Imam Reza Hospital Ebn Sina Street Mashhad, Iran Tel.: [phone] Fax: [phone] E-mail: [email protected]; [email protected]

R. Sadeghi

S. Ramin, M.D., Assistant Professor Nuclear Medicine Research Center Mashhad University of Medical Sciences Imam Reza Hospital Ebn Sina Street Mashhad, Iran Tel.: [phone] Fax: [phone] E-mail: [email protected]; [email protected]

D.W. Chicken

S. Ramin, M.D., Assistant Professor Nuclear Medicine Research Center Mashhad University of Medical Sciences Imam Reza Hospital Ebn Sina Street Mashhad, Iran Tel.: [phone] Fax: [phone] E-mail: [email protected]; [email protected]

M. Keshtgar

S. Ramin, M.D., Assistant Professor Nuclear Medicine Research Center Mashhad University of Medical Sciences Imam Reza Hospital Ebn Sina Street Mashhad, Iran Tel.: [phone] Fax: [phone] E-mail: [email protected]; [email protected]